Eikonoklastes Therapeutics
Eikonoklastes Therapeutics


Cincinnati, OH, USA · North America


Biotechnology · DeepTech · Health


1 - 10 employees


Series A

founded in


Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment. It has recently been discovered that certain pathological cells – but not healthy cells – including cancers with high unmet need and high mortality such as triple-negative breast cancer, ovarian cancer, metastatic melanoma, and a broad range of other solid tumors, express tissue factor on the surface of their cell membranes. Several other non-cancerous indications such as endometriosis also highly and selectively express tissue factor.

Something looks off?
Open jobs at Eikonoklastes Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.